Accellta

Accellta Ltd. is a biotechnology company based in Haifa, Israel, specializing in the development of innovative technologies for stem cell culture. Founded in 2012, the company focuses on creating affordable and high-quality solutions for the cultivation of pluripotent stem cells, progenitors, and differentiated cells, which are essential for drug discovery, regenerative medicine, and research applications. Accellta's proprietary technologies include Maxells and Singles, along with custom protocols for directed differentiation. The company also operates a manufacturing facility dedicated to the industrial production of cells, ensuring that it meets the growing demand for quality stem cell products. With a foundation built on over 15 years of research at the Stem Cell Center of the Technion’s Rappaport Faculty of Medicine, Accellta aims to enhance the efficiency and effectiveness of stem cell applications in clinical settings.